As of Jan 20
| -0.05 / -2.33%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +304.76% increase from the last price of 2.10.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.